awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37022524-1D09F8C7-0872-4028-9A03-AFE12EDA35A2
Q37022524-1D09F8C7-0872-4028-9A03-AFE12EDA35A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-1D09F8C7-0872-4028-9A03-AFE12EDA35A2
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
P2860
Q37022524-1D09F8C7-0872-4028-9A03-AFE12EDA35A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-1D09F8C7-0872-4028-9A03-AFE12EDA35A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbf5441ca4ea741c442b13aa22bc4b21fcfa3201
P2860
Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer.